Revive Therapeutics's total assets for Q1 2026 were C$249.81K, an increase of 21.85% from the previous quarter. TSE:RVV total liabilities were C$3.75M for the fiscal quarter, a 2.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.